Methods and compositions for treating an ocular neovascular disease
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 28, 2009
Grant Date -
Jan 6, 2005
app pub date -
Jul 21, 2004
filing date -
Mar 1, 1993
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention comprises a group of compounds that effectively inhibit angiogenesis. More specifically, the invention comprises the compound EM-138 and its use in the inhibition of angiogenesis and treatment of angiogenesis associate diseases, including the inhibition of tumor growth and metastasis.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully